AFP and hepatocellular carcinoma: The present study identified male gender, age> 65 years, AFP> 20ng/ml, multiple recurrent tumors, and 1st recurrence occurring within 2 years bear higher risks of 2nd recurrence after treatment for recurrent HCC.